中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 3
Mar.  2011

Role of adiponectin in liver fibrogenesis:progress in basic and clinical research

  • Published Date: 2011-03-20
  • Adiponectin possesses many biological effects.Recent studies have found that adiponectin can inhibit the development of hepatic fibrosis.Some animal experiments demonstrate that adiponectin-knockout (ADN-KO) mice tend to develop severe hepatic fibrosis which may be associated with anti-oxidative stress and anti-inflammatory effects of adiponectin.Hepatic stellate cell (HSC) play a central role in liver fibrogenesis.Studies showed that adiponectin can inhibit proliferation, migration of HSC and promote its apoptosis.Clinical researches also reported that adiponectin was related to progression of hepatic fibrosis in chronic liver diseases, which is a new way for the non-invasive diagnosis of hepatic fibrosis.It is necessary to investigate the precise mechanism of adiponectin on hepatic fibrosis.

     

  • [1]Hug C, Wang J, Ahmad NS, et al.T-cadherin is a receptorfor hexameric and high-molecularweight forms ofAcrp30/adiponectin[J].Proc Natl Acad Sci U S A, 2004, 101 (28) :10308-10313.
    [2]Kamada Y, Tamura S, Matsumoto H, et al.Enhancedcarbon tetrachloride-induced liver fibrosis in mice lackingadiponectin[J].Gastroenterology, 2003, 125 (6) :1796-1807.
    [3]Handy JA, Saxena NK, Fu P, et al.Adiponectin activationof AMPK disrupts leptin-mediated hepatic fibrosis viasuppressors of cytokine signaling (SOCS-3) [J].J CellBiochem, 2010, 110 (5) :1195-1207.
    [4]Asano T, Omata M, Kadowaki T, et al.Adiponectin knockoutmice on high fat diet develop fibrosing steatohepatitis[J].JGastroenterol Hepatol, 2009, 24 (10) :1669-1676.
    [5]Kamada Y, Matsumoto H, Tamura S, et al.Hypoadip-onectinemia accelerates hepatic tumor formation in anonalcoholic steatohepatitis mouse model[J].J Hepatol, 2007, 47 (4) :556-564.
    [6]Fukushima J, Kamada Y, Yoshida Y, et al.Adiponectinprevents progression of steatohepatitis in mice byregulating oxidative stress and Kupffer cell phenotypepolarizationhep[J].Hepatol Res, 2009, 39 (7) :724-738.
    [7]Tomita K, Oike Y, Teratani T, et al.Hepatic AdipoR2 signalingplays a protective role against progression of nonalcoholicsteatohepatitis in mice[J].Hepatology, 2008, 48 (2) :458-473.
    [8]You M, Rogers CQ.Adiponectin:a key adipokine in alcoholicfatty liver[J].Exp Biol Med, 2009, 234 (8) :850-859.
    [9]Ding X, Saxena NK, Lin S, et al.The roles of leptin andadiponectin:a novel paradigm in adipocytokine regulation ofliver fibrosis and stellate cell biology[J].Am J Pathol, 2005, 166 (6) :1655-1669.
    [10]Da Silva Morais A, Abarca-Quinones J, Guigas B, et al.Development of hepatic fibrosis occurs normally in AMPK-deficient mice[J].Clin Sci, 2009, 118 (6) :411-420.
    [11]Zhang J, Tan L, Lin J, et al.Adenovirus-mediatedoverexpression of AMP-activated protein kinase inducesLX2 cell apoptosis[J].Nan Fang Yi Ke Da Xue Xue Bao, 2007, 27 (6) :821-823.
    [12]Adach M, Brenneri DA.High molecular weight adip-onectininhibits proliferation of hepatic stellate cells via activationof adenosine monophosphate-activated protein kinase[J].Hepatology, 2008, 47 (2) :677-685.
    [13]Urtasun R, Nieto N.Hepatic stellate cells and oxidativestress[J].Rev Esp Enferm Dig, 2007, 99 (4) :223-230.
    [14]Aram G, Potter JJ, Liu X, et al.Lack of inducible nitricoxide synthase leads to increased hepatic apoptosis anddecreased fibrosis in mice after chronic carbon tetrachlorideadministration[J].Hepatology, 2008, 47 (6) :2051-2058.
    [15]Liu YD, Ramezani-Moghadam M, George J, et al.Ku-pfferCells and s inusoidal endothelial cells mediate the anti-fibrogenic effects of adiponectin on hepatic stellate cells[R].Hepatol Int, 2010, 4 (1) :2-93.
    [16]Musso G, Gambino R, Biroli G, et al.Hypoadiponec-tinemiapredicts the severity of hepatic fibrosis and pancreaticbeta-cell dysfunction in nondiabetic nonobese patients withnonalcoholic steatohepatitis[J].Am J Gastroenterol, 2005, 100 (11) :2438-2446.
    [17]Kaser S, Moschen A, Cayon A, et al.Adiponectin and itsreceptors in nonalcoholic steatohepatitis[J].Gut, 2005, 54 (1) :117-121.
    [18]Nazal L, Riquelme A, Soíls N, et al.Hypoadipone-ctinemiaand its association with liver fibrosis in morbidly obese patients[J].Obes Surg, 2010, 20 (10) :1400-1407.
    [19]Wedemeyer I, Bechmann LP, Odenthal M, et al.Adip-onectininhibits steatotic CD95/Fas up-regulation by hepatocytes:Therapeutic implications for hepatitis C[J].J Hepatol, 2009, 50 (1) :140-149.
    [20]Jonsson JR, Moschen AR, Hickman LJ, et al.Adiponectinand its receptors in patients with chronic hepatitis C[J].JHepatol, 2005, 43 (6) :929-936.
    [21]Latif HA, Assal HS, Mahmoud M, et al.Role of serumadiponectin level in the development of liver cirrhosis inpatients with hepatitis C virus[J].Clin Exp Med, 2010, Aug17.[Epub ahead of print]
    [22]Hui CK, Zhang HY, Lee NP, et al.Serum adiponectin isincreased in advancing liver fibrosis and declines with reduction in fibrosis in chronic hepatitis B[J].J Hepatol, 2007, 47 (2) :191-202.
    [23]Liu CJ, Chen PJ, Lai MY, et al.High serum adiponectincorrelates with advanced liver disease in patients with chronichepatitis B virus infection[J].Hepatol Int, 2009, 3 (2) :364-370.
    [24]Tacke F, Horn R, Luedde T, et al.High adiponectin in chronic liverdisease and cholestasis suggests biliary route of adiponectinexcretion in vivo[J].J Hepatol, 2005, 42 (5) :666-673.
    [25]Wong VW, Wong GL, Yu J, et al.Interaction of adipokinesand hepatitis B virus on histological liver injury in theChinese[J].Am J Gastroenterol, 2010, 105 (1) :132-138.
  • Relative Articles

    [1]Xiang XiaoHui, Mao Jun, Li Hai. Expression and clinical significance of CCDC34 in hepatocellular carcinoma:An analysis based on The Cancer Genome Atlas database[J]. Journal of Clinical Hepatology, 2020, 36(5): 1050-1054. doi: 10.3969/j.issn.1001-5256.2020.05.020
    [2]Dong XiaoPeng, Wang LiJuan, Zhao ChunLin, Zhang JianPing, Pan HaiBang, Yi JianFeng, Shi YuHong. A bioinformatics analysis of acute pancreatitis based on gene expression microarray and drug screening[J]. Journal of Clinical Hepatology, 2020, 36(3): 636-640. doi: 10.3969/j.issn.1001-5256.2020.03.033
    [3]Chen Hao, Hao JianHeng, Li ZhenCheng, Xu HuiChao, Gao Yan, Miao YuChuan, Hao HuiQin, Liu Yang. Screening for differentially expressed genes in mice with autoimmune hepatitis and effect of saikosaponin-d on the expression of several differentially expressed genes[J]. Journal of Clinical Hepatology, 2020, 36(4): 840-846. doi: 10.3969/j.issn.1001-5256.2020.04.026
    [4]Huang XiangJun, Zhang WenXing. Expression features and clinical significance of the microRNA-888 gene family in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2019, 35(1): 119-122. doi: 10.3969/j.issn.1001-5256.2019.01.022
    [5]Fan Bin, Zhang Yong, Li JinMao, Liu Tao, Zhang JiaYao. Association between the expression of centromere protein F and prognosis in patients with hepatocellular carcinoma:An analysis using GEO database[J]. Journal of Clinical Hepatology, 2018, 34(7): 1475-1480. doi: 10.3969/j.issn.1001-5256.2018.07.022
    [6]Mai JingYin, Chen TianYang, Cheng Yang. Changes in microRNA expression profile in the liver of mice with nonalcoholic fatty liver disease induced by high-fat diet[J]. Journal of Clinical Hepatology, 2017, 33(12): 2372-2375. doi: 10.3969/j.issn.1001-5256.2017.12.023
    [7]Wang QingLan, Tao YanYan, Lu: Jing, Liu Ping, Liu ChengHai. Antifibrotic mechanism of Fuzheng Huayu prescription by regulation of the differential expression of microRNAs in mouse liver[J]. Journal of Clinical Hepatology, 2016, 32(3): 503-508. doi: 10.3969/j.issn.1001-5256.2016.03.022
    [8]Xiao ChunYang, Li QinKai, Yu JingXia, Liu Ting, Lu LunGen, Xu MingYi. Risk genes for the development of chronic hepatitis B cirrhosis assessed by prediction analysis of microarrays[J]. Journal of Clinical Hepatology, 2016, 32(7): 1323-1329. doi: 10.3969/j.issn.1001-5256.2016.07.022
    [9]Li HaiPing, Yu ZongTao, Fan JinBo, Gao Bo, Zhang JiCai. DNMT expression in hepatocellular cancer[J]. Journal of Clinical Hepatology, 2013, 29(7): 525-528. doi: 1001-5256 (2013) 07-0525-04
    [10]Lu: Xin, Yin Wen, Sun MengNing, Huang XiaoJun, Yang Jing, Yao Min, Xue XiaoPing, Jia ZhanSheng, Xu ZhiKai. Construction of eukaryotic expression vector of HCV CTL epitopes and establishment of stable transfected CHO cell line[J]. Journal of Clinical Hepatology, 2011, 27(1): 45-48.
    [11]Li TieHan, Tang Bo, Tang JiHong, Fu BiMang, Zhu Hong, Zhang Jie. Expression of heme oxygenase in the kidney of experimental cirrhotic rat[J]. Journal of Clinical Hepatology, 2011, 27(3): 265-267.
    [12]Gao BaoHua, Liu Bing, Zheng JianYun, Wu FangXiong, Wang Wen, Li Lei, Niu ChunYan. The study of the expression of COX-2 and CDKN2A in chronic hepatitis B and liver cirrhosis[J]. Journal of Clinical Hepatology, 2011, 27(3): 273-276.
    [13]Li HaiPing, Tao JianShu, Gao Bo, Yu ZongTao, Li WenCui, Zhang JiCai. The expression and clinical significance of resistance gene in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2011, 27(9): 972-975.
    [14]Chen LiDong, Cheng Jun, Hong Yuan, Zhang LianFeng, Han Li, Guo Jiang. Construction of the prokaryotic expression vector of NS5ATP4A gene and its expression[J]. Journal of Clinical Hepatology, 2010, 26(4): 371-373.
    [15]Cheng LiangBin, Cheng Ming, Liu Yan. The effect of Kangxian ruangan granule on the expression of nuclear factor-κB gene in fibrotic rat liver[J]. Journal of Clinical Hepatology, 2010, 26(4): 410-412.
    [16]Lu YinYing, Wang Lin, Liu Yan, Li Ke, Cheng Jun, Zhang LingXia, Li Li. Cloning and expression of gene of hepatitis B virus e antigen in yeast[J]. Journal of Clinical Hepatology, 2003, 19(3): 166-168.
    [17]Lu DongDong, Zhang XiRan. The primary study of expression and function of CK2α subunit in liver cancer[J]. Journal of Clinical Hepatology, 2003, 19(4): 240-241.
    [19]Wang AiMin, Wang BaoEn, Yang YueWei, Zhang Bin, Jiang LongAn, Du ShuangCun. Interstitial collagenase gene expression in patients with chronic liver disease[J]. Journal of Clinical Hepatology, 2000, 16(2): 90-91+124.
  • 加载中
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 3.9 %FULLTEXT: 3.9 %META: 93.7 %META: 93.7 %PDF: 2.5 %PDF: 2.5 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 1.5 %其他: 1.5 %其他: 0.3 %其他: 0.3 %China: 0.3 %China: 0.3 %上海: 2.7 %上海: 2.7 %丽水: 0.9 %丽水: 0.9 %北京: 9.7 %北京: 9.7 %南宁: 0.9 %南宁: 0.9 %台州: 3.3 %台州: 3.3 %吉林: 0.6 %吉林: 0.6 %哥伦布: 0.3 %哥伦布: 0.3 %张家口: 3.6 %张家口: 3.6 %杭州: 0.9 %杭州: 0.9 %武汉: 0.3 %武汉: 0.3 %洛阳: 0.3 %洛阳: 0.3 %深圳: 0.3 %深圳: 0.3 %湖州: 3.0 %湖州: 3.0 %石家庄: 0.6 %石家庄: 0.6 %芒廷维尤: 35.3 %芒廷维尤: 35.3 %莫斯科: 0.3 %莫斯科: 0.3 %衢州: 1.5 %衢州: 1.5 %西宁: 31.6 %西宁: 31.6 %金华: 0.3 %金华: 0.3 %铜陵: 0.3 %铜陵: 0.3 %长春: 0.9 %长春: 0.9 %其他其他China上海丽水北京南宁台州吉林哥伦布张家口杭州武汉洛阳深圳湖州石家庄芒廷维尤莫斯科衢州西宁金华铜陵长春

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (4185) PDF downloads(1045) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return